mtm laboratories opens subsidiaries in Italy, France and Spain to support the commercialization of its diagnostic products
mtm laboratories announced the opening of new subsidiaries by the Company in Italy (Milan), France (Paris) and Spain (Madrid) in order to commercialize its CE-labeled diagnostic products in Europe. When combined with Germany, these additional European markets represent approximately 65% of the total European cervical cancer screening market. Through these new subsidiaries, mtm plans to commercialize its proprietary p16INK4a based products in major European markets starting in January 2007.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Molecular archeology: 1200-year-old DNA sequences from Madagascar lead to the discovery of an extinct tortoise - Genetic analyses reveal the lost world of giant tortoises in the western Indian Ocean

Organic foods may be an unsuspected source of dietary arsenic
